News

Insiders Snap Up These 2 Stocks on the Dip — Here’s Why They Draw Plaudits from Goldman Sachs

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Precigen: This Billion-Dollar Approval Is Still Undervalued

Earlier today, it was announced that Precigen’s PAPZIMEOS (formerly PRGN-2012) was FDA-approved for adults with RRP. Read why ...